PASG
Passage Bio, Inc.$4.91+0.47 (+10.47%)Prev Close$4.44·MCap$27.9M·P/E—·Vol55.4K·Yield—
▲
Buys (12M)
1
$206.1K
▼
Sells (12M)
4
$226.4K
◆
Net Activity
Net Seller
$20.3K
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at Passage Bio, Inc. (PASG) has been mixed between buying and selling, with 1 insider purchase totaling $206.1K and 4 insider sales totaling $226.4K. The most recent insider transaction was by Lynx1 Capital Management LP (10 percent owner), who purchased $206.1K worth of shares on Jun 29, 2026. Passage Bio, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $27.9M.
PASG Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Lynx1 Capital Management LP | 10 percent owner | Buy | 50,055 | $4.12 | $206.1K1.6% OS | 673,759 |
| Jan 12, 2026 | Borthwick Kathleen | officer: CFO | Sell | 2,062 | $18.44 | $38.0K | 5,402-28% |
| Jan 12, 2026 | Chou William | director, officer: PRESIDENT AND CEO | Sell | 4,076 | $18.44 | $75.2K | 6,524-38% |
| Jan 8, 2026 | Borthwick Kathleen | CFO | Sell | 2,062 | $18.44 | $38.0K | 0 |
| Jan 8, 2026 | Chou William | PRESIDENT AND CEO | Sell | 4,076 | $18.44 | $75.2K | 0 |
| Feb 12, 2025 | Borthwick Kathleen | CFO | Sell | 3,183 | $0.53 | $1.7K | 41,283 |
| Jan 14, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 223,219 | $0.64 | $142.2K7.0% OS | 7,131,636 |
| Jan 8, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 147,024 | $0.70 | $103.3K4.6% OS | 7,385,388 |
| Dec 31, 2024 | Lynx1 Capital Management LP | 10% Owner | Buy | 373,645 | $0.65 | $241.0K11.6% OS | 9,256,953 |
| Dec 26, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 230,321 | $0.60 | $138.2K7.2% OS | 7,404,869 |
| Dec 11, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 62,276 | $0.83 | $52.0K1.9% OS | 7,643,285 |
| Dec 6, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 97,103 | $0.80 | $77.3K3.0% OS | 7,718,369 |
| Nov 27, 2024 | Lynx1 Capital Management LP | 10% Owner | Buy | 456,353 | $0.62 | $284.5K14.2% OS | 8,883,308 |
| Sep 23, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 39,300 | $0.71 | $27.9K1.2% OS | 7,794,569 |
| Sep 18, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 200,131 | $0.73 | $146.7K6.2% OS | 7,970,900 |
| Feb 13, 2024 | Borthwick Kathleen | SVP, INTERIM CFO | Sell | 1,470 | $0.97 | $1.4K | 28,466 |
| Feb 13, 2024 | Forman Mark S | CHIEF MEDICAL OFFICER | Sell | 1,638 | $0.97 | $1.6K | 48,631 |
| Jan 3, 2024 | Borthwick Kathleen | SVP, Interim CFO | Sell | 10,672 | $0.91 | $9.7K | 25,936-29% |
| Jan 3, 2024 | Cale Edgar B. | GC & Corporate Secretary | Sell | 15,813 | $0.91 | $14.4K | 45,995-26% |
| Jan 3, 2024 | Forman Mark S | Chief Medical Officer | Sell | 15,813 | $0.91 | $14.4K | 45,269-26% |
| Aug 1, 2023 | King Simona | Chief Financial Officer | Sell | 11,453 | $0.88 | $10.1K | 23,994-32% |
| Jun 29, 2023 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 1,192,577 | $0.84 | $1.00M37.2% OS | 8,034,000 |
| Jun 20, 2023 | Fotopoulos Alexandros | Chief Technical Officer | Sell | 4,052 | $0.93 | $3.8K | 28,693 |
| Apr 20, 2023 | King Simona | Chief Financial Officer | Sell | 2,053 | $1.05 | $2.2K | 2,053-50% |
| Dec 2, 2022 | Kapadia Sandip | Director | Sell | 5,000 | $1.19 | $6.0K | 0Exit |
| Nov 25, 2022 | Fotopoulos Alexandros | Chief Technical Officer | Sell | 3,720 | $1.33 | $4.9K | 20,245 |
| Nov 18, 2022 | Toernsen Monika Maria | Chief Commercial Officer | Sell | 1,681 | $1.51 | $2.5K | 3,319-34% |
| May 5, 2022 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 525,000 | $1.94 | $1.02M16.4% OS | 6,841,423 |
| Mar 23, 2022 | Goldsmith Bruce A | CEO and President | Buy | 10,000 | $3.15 | $31.5K | 15,983+167% |
| Jan 24, 2022 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 369,100 | $5.42 | $2.00M11.5% OS | 6,634,723 |
| Jan 20, 2022 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 168,300 | $5.38 | $905.2K5.2% OS | 6,265,623 |
| Jan 13, 2022 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 150,000 | $5.61 | $841.1K4.7% OS | 6,097,323 |
| May 21, 2021 | Goldsmith Bruce A | CEO and President | Buy | 2,000 | $13.12 | $26.2K | 5,983+50% |
| May 21, 2021 | Morris Richard Steven | Chief Financial Officer | Buy | 2,171 | $13.82 | $30.0K | 5,454+66% |
| Mar 17, 2021 | Romano Gary | Chief Medical Officer | Sell | 10,000 | $21.10 | $211.0K | 1,617-86% |
PASG Insider Buying Activity
The following table shows recent insider purchases of Passage Bio, Inc. (PASG) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Lynx1 Capital Management LP | 10 percent owner | Buy | 50,055 | $4.12 | $206.1K1.6% OS | 673,759 |
| Dec 31, 2024 | Lynx1 Capital Management LP | 10% Owner | Buy | 373,645 | $0.65 | $241.0K11.6% OS | 9,256,953 |
| Nov 27, 2024 | Lynx1 Capital Management LP | 10% Owner | Buy | 456,353 | $0.62 | $284.5K14.2% OS | 8,883,308 |
| Jun 29, 2023 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 1,192,577 | $0.84 | $1.00M37.2% OS | 8,034,000 |
| May 5, 2022 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 525,000 | $1.94 | $1.02M16.4% OS | 6,841,423 |
| Mar 23, 2022 | Goldsmith Bruce A | CEO and President | Buy | 10,000 | $3.15 | $31.5K | 15,983+167% |
| Jan 24, 2022 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 369,100 | $5.42 | $2.00M11.5% OS | 6,634,723 |
| Jan 20, 2022 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 168,300 | $5.38 | $905.2K5.2% OS | 6,265,623 |
| Jan 13, 2022 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 150,000 | $5.61 | $841.1K4.7% OS | 6,097,323 |
| May 21, 2021 | Goldsmith Bruce A | CEO and President | Buy | 2,000 | $13.12 | $26.2K | 5,983+50% |
| May 21, 2021 | Morris Richard Steven | Chief Financial Officer | Buy | 2,171 | $13.82 | $30.0K | 5,454+66% |
PASG Insider Selling Activity
The following table shows recent insider sales of Passage Bio, Inc. (PASG) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Borthwick Kathleen | officer: CFO | Sell | 2,062 | $18.44 | $38.0K | 5,402-28% |
| Jan 12, 2026 | Chou William | director, officer: PRESIDENT AND CEO | Sell | 4,076 | $18.44 | $75.2K | 6,524-38% |
| Jan 8, 2026 | Borthwick Kathleen | CFO | Sell | 2,062 | $18.44 | $38.0K | 0 |
| Jan 8, 2026 | Chou William | PRESIDENT AND CEO | Sell | 4,076 | $18.44 | $75.2K | 0 |
| Feb 12, 2025 | Borthwick Kathleen | CFO | Sell | 3,183 | $0.53 | $1.7K | 41,283 |
| Jan 14, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 223,219 | $0.64 | $142.2K7.0% OS | 7,131,636 |
| Jan 8, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 147,024 | $0.70 | $103.3K4.6% OS | 7,385,388 |
| Dec 26, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 230,321 | $0.60 | $138.2K7.2% OS | 7,404,869 |
| Dec 11, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 62,276 | $0.83 | $52.0K1.9% OS | 7,643,285 |
| Dec 6, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 97,103 | $0.80 | $77.3K3.0% OS | 7,718,369 |
| Sep 23, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 39,300 | $0.71 | $27.9K1.2% OS | 7,794,569 |
| Sep 18, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 200,131 | $0.73 | $146.7K6.2% OS | 7,970,900 |
| Feb 13, 2024 | Borthwick Kathleen | SVP, INTERIM CFO | Sell | 1,470 | $0.97 | $1.4K | 28,466 |
| Feb 13, 2024 | Forman Mark S | CHIEF MEDICAL OFFICER | Sell | 1,638 | $0.97 | $1.6K | 48,631 |
| Jan 3, 2024 | Borthwick Kathleen | SVP, Interim CFO | Sell | 10,672 | $0.91 | $9.7K | 25,936-29% |
| Jan 3, 2024 | Cale Edgar B. | GC & Corporate Secretary | Sell | 15,813 | $0.91 | $14.4K | 45,995-26% |
| Jan 3, 2024 | Forman Mark S | Chief Medical Officer | Sell | 15,813 | $0.91 | $14.4K | 45,269-26% |
| Aug 1, 2023 | King Simona | Chief Financial Officer | Sell | 11,453 | $0.88 | $10.1K | 23,994-32% |
| Jun 20, 2023 | Fotopoulos Alexandros | Chief Technical Officer | Sell | 4,052 | $0.93 | $3.8K | 28,693 |
| Apr 20, 2023 | King Simona | Chief Financial Officer | Sell | 2,053 | $1.05 | $2.2K | 2,053-50% |
| Dec 2, 2022 | Kapadia Sandip | Director | Sell | 5,000 | $1.19 | $6.0K | 0Exit |
| Nov 25, 2022 | Fotopoulos Alexandros | Chief Technical Officer | Sell | 3,720 | $1.33 | $4.9K | 20,245 |
| Nov 18, 2022 | Toernsen Monika Maria | Chief Commercial Officer | Sell | 1,681 | $1.51 | $2.5K | 3,319-34% |
| Mar 17, 2021 | Romano Gary | Chief Medical Officer | Sell | 10,000 | $21.10 | $211.0K | 1,617-86% |
PASG Insiders
Similar Stocks to PASG
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B